on M1 Kliniken AG (isin : DE000A0STSQ8)
M1 Kliniken AG Announces Dividend and Positive Forecast for 2024
On May 7, 2024, M1 Kliniken AG's Supervisory Board officially approved the 2023 annual financial statements and resolved along with the Executive Board to propose a dividend of EUR 0.50 per share at the Annual General Meeting. The approval confirms the company's firm financial footing and readiness to deliver shareholder value.
Looking ahead, M1 Kliniken AG expects a significant increase in sales and earnings for the 2024 financial year. Specifically, the company forecasts sales in the Beauty segment to reach between EUR 80 million and EUR 90 million, up from EUR 70.8 million in 2023. Moreover, earnings before interest and taxes (EBIT) are projected to lie between EUR 18 million and EUR 22 million, marking an improvement from the EUR 15.5 million recorded in 2023.
The full 2023 annual report is scheduled for release on May 23, 2024. These forward-looking statements suggest a positive trajectory for M1 Kliniken AG underpinned by robust growth strategies in the aesthetic healthcare sector.
R. H.Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all M1 Kliniken AG news